We studied the effects of glucagon, dibutyryl cyclic AMP and dexamethasone on the rate of ['4C]pantothenate conversion to CoA in adult rat liver parenchymal cells in primary culture. The presence of 30nM-glucagon increased the rate by about 1.5-fold relative to control cultures (range 1.4-2.3) and 2.4-fold relative to cultures containing 1-3 m-i.u. of insulin/ml. The half-maximal effect was obtained at 3 nM-glucagon. Dibutyryl cyclic AMP plus theophylline also enhanced the rate by about 1.5-fold. Dexamethasone acted synergistically with glucagon; glucagon at 0.3nm had no effect when added alone, but resulted in a 1.7-fold enhancement when added in the presence of dexamethasone (maximum effect at 50nM). The 1.4-fold enhancement caused by the addition of saturating glucagon concentrations was increased to a 3-fold overall enhancement by the addition of dexamethasone. However, dexamethasone added alone over the range 5 nm to 5 M had no (Bremer, et al., 1972) and a pyrophosphatase specific for dephospho-CoA (Skrede, 1973 ). An amidohydrolase that catalyses the hydrolysis of pantetheine to pantothenate has also been identified (Dupre et al., 1973; Abiko, 1975) .
[for reviews, see Plaut et al. (1974) and Abiko (1975) ]. Degradation of CoA occurs via a phosphatase specific for CoA (Bremer, et al., 1972) and a pyrophosphatase specific for dephospho-CoA (Skrede, 1973 ). An amidohydrolase that catalyses the hydrolysis of pantetheine to pantothenate has also been identified (Dupre et al., 1973; Abiko, 1975) .
Evidence that the metabolism of the pantothenate * To whom reprint requests should be addressed.
vivo has come from comparisons of CoA concentrations in tissues of control rats with those in alloxan-diabetic rats and from studies of rats subjected to various feeding regimens Tubbs & Garland, 1964; Kondrup & Grunnet, 1973) . In general, livers of rats deprived of food for 21-48 h have total CoA (CoASH plus acylated CoA) concentrations 1.6-2-fold higher than those in fed or re-fed rats, and the livers of alloxan-diabetic rats have total CoA concentrations 2-fold higher than in the normal controls . Neither of these conditions produced increases in total CoA concentrations in the heart . Starved rats force-fed with glucose also had a 2-3-fold lower rate of incorporation of [14C] pantothenate into CoA in the liver in vivo than did starved rats (Smith, 1978) . The tissue cysteine and pantothenate contents, the specific radioactivity of the tissue pantothenate and the influx of pantothenate into the tissue were all unable to account for the differences in rate of incorporation of [14C] pantothenate into CoA (Smith, 1978) . This suggested that the locus of hormonal action involved an enzyme(s) in the metabolic pathway between intracellular pantothenate and CoA. An involvement of glucocorticoids in the regulation of CoA concentration in the liver has also been suggested from experiments in vivo. Nakamura et al. (1970) reported that there was a marked decrease in the amount of CoA in the livers of adrenalectomized rats (relative to sham-operated controls), and that daily administration of prednisolone resulted in an initial increase in CoA followed by a decrease during longer periods of administration.
The above studies relied on manipulation of hormonal concentrations in vivo to demonstrate hormonal regulation of CoA concentration or pantothenate -. CoA metabolism. However, the intra-tissue flux of many other hormones and metabolites is associated with changing concentrations of insulin, glucagon or glucocorticoids, and thus the hormonal effects could occur through an indirect route. In order to determine if these hormones act on liver pantothenate -. CoA metabolism by direct interaction at the cellular level, we have used rat liver parenchymal cells maintained in primary culture. This technique employs a chemically defined growth medium which permits the addition of hormones and other agents at known concentrations. The experiments established a direct effect of glucagon and glucocorticoids on the rate of conversion of pantothenate to CoA. A preliminary report of this work has been presented (Smith & Savage, 1979 
Methods
Isolation and cultivation ofrat hepatocytes Rat liver parenchymal cells were isolated in essentially pure form by using the collagenase perfusion technique described previously (Savage & Green, 1976; Savage & Bonney, 1978) as modified by Seglen (1973) in that 2.5 mM-Ca2+ was added to the collagenase perfusion medium. The procedure permits the isolation of 2 x 108-4 x 108 hepatocytes from one liver, with a viability of greater than 85%, as judged by exclusion of 1.15% Trypan Blue.
About 3 x 106-4 x 106 cells were plated in 25 cm2 Falcon flasks in 5 ml of medium M-199 containing 15% (w/v) foetal calf serum, 10m-i.u. of insulin/ml, 0.37mg of penicillin/ml and 100,g of streptomycin/ml. Medium M-199 was used because it has a low pantothenate concentration (46 nM). Hepes was added to a final concentration of 25mm, and the medium was adjusted to pH 7.3-7.4 at the time of cell plating. The cells were allowed to attach to the flask for 2-4h at 370C, and the medium was replaced with 5ml of fresh M-199 medium containing foetal calf serum and insulin. Thereafter, M-199 medium without serum was used and the medium was changed daily. Unless otherwise indicated, the cultures were maintained for 2 days and experiments were initiated during the third day of culture. Internal ATP concentrations in the range 10.5-27.Onmol/mg of protein was measured by luciferase assay (Bergmeyer, 1973) . This is comparable with the values measured in freeze-clamped livers (Woods et al., 1970 The cells were extracted within 24 h. Freezing cells for longer periods resulted in a significant loss of CoA. The culture flasks were thawed on ice, and 0.5 ml of cold 3% (w/v) HCl04 and 0.02 ml of 1.OM-dithiothreitol were added to each flask. The cells were scraped from the flask with a rubber 'policeman' and the mixture was transferred to a centrifuge tube. In order to convert acyl-CoA derivatives to CoASH, a basic hydrolysis was carried out as follows. The mixture in each centrifuge tube was adjusted to pH 11.0-11.5 by the addition of an appropriate volume (about 0.1 ml) of 3 m-KOH. This was heated to 550C for 0min with shaking, followed by rapid cooling on ice. The pH was adjusted to 5-6 by the addition of approx. 0.05 ml of 0.5 M-triethanolamine containing 6% (w/v) HCl04. This was centrifuged at 8000g for 10min at 40C. Samples of this supernatant were then taken for pantothenate determinations and for DEAE-Sephadex chromatography (as described below). The pantothenate was assayed with Lactobacillus plantarum (Skeggs & Wright, 1944 Hansford, 1974) .
Determination of radioactivity in CoA and intermediates
In order to determine the amount of 14C radioactivity in CoA, pantothenate and other intermediates, ascending chromatography on Whatman DEAE-cellulose paper (DE-81) was performed as described by Smith (1978) . Portions (50 or lOO,ul) of the cell extracts were spotted on the paper and the chromatograms were developed in the ascending direction by using freshly distilled formic acid (0.5 M) in aqueous solution (pH 3.1). The developing time was usually 3-4 h at room temperature. Standards consisting of CoA, dephospho-CoA pantetheine and phosphopantetheine were chromatographed under identical conditions, and the spots were identified by spraying for thiol groups with cyanide and nitroprusside (Smith, 1978) . In addition, [3HICoA or
[14C]pantothenate were chromatographed alone or in the presence of non-radioactive cell extracts.
The air-dried chromatograms were cut into 0.63 or 1.27 cm segments and counted for radioactivity in 7 ml of New England Nuclear Formula 963 scintillation fluid. The specific radioactivity of pantothenate in the cells, was calculated from the amount of radioactivity appearing in the area of the chromatogram corresponding to pantothenate and the total amount of pantothenate in the sample.
Results

Incorporation of [14C] pantothenate into CoA in rat liverparenchymal cells
The amount of radioactivity incorporated into CoA was determined after incubating the hepatocytes with [14C]pantothenate for time intervals ranging from 3 to 20h. Cellular extracts were subjected to mild alkaline conditions to hydrolyse acyl-CoA derivatives to free CoASH, followed by addition of HCl04 to reprecipitate protein. The incorporation of radioactivity into components of the acid-soluble fraction is shown in Fig. l(a) , and the incorporation into the final HCl04-insoluble fraction is shown in Fig. 1(b) . Major peaks of radioactivity appeared only in the positions of pantothenate and CoA, which together accounted for 93.0-95.7% of all the cellular radioactivity. After 20h of incubation, the HCl04-insoluble radioactivity accounted for approx. 2.7% of the total cellular radioactivity. Over the 20h of incubation, total cellular protein decreased by 16%, 3.8% in the first lOh. The radioactivity appearing in pantothenate rose sharply and remained fairly constant over the 3-20h of incubation, whereas radioactivity appearing in CoA rose continuously over this time period. Incorporation of radioactivity before 2.5 h was difficult to measure at the concentration of cells employed, and experimental values are most often taken after lOh of incubation. Fig. 2 . The CoA peak was cleanly separated from the pantothenate peak and there was only a small accumulation of pathway intermediates. There was far more radioactivity in the CoA peak of those cells incubated with glucagon.
The amount of pantothenate converted to CoA was calculated by dividing the amount of radioactivity in CoA/mg of protein by the specific radioactivity of intracellular pantothenate. This value eliminated differences between individual flasks by correcting for possible differences in protein content of the culture flasks or for differences in specific radioactivity of the precursor, pantothenate. This decreased the standard deviation for a given experimental condition. A graph of the incorporation of pantothenate into CoA as a function of glucagon concentration is shown in Fig.  3 . Half-maximal activation occurred at about 3 nMglucagon and no activation was present at 0.3 nM; 30nM was near saturation. This value shows the largest stimulation by glucagon (approx. 2-fold) observed in the course of these experiments. Two additional titrations, in which the maximum stimulation by glucagon was in the range 40-60% (relative to controls), also gave values of about 3 nM-glucagon for the concentration required for half-maximum activation. [Glucagon] (nM) Fig. 3 and 30 nM-glucagon, the rate of incorporation was 35% higher than in the presence of glucagon alone, and 95% higher than in the controls. The maximum effect was achieved with 50nM-dexamethasone. In the presence of dibutyryl cyclic AMP plus theophylline, 0.5,uM-dexamethasone increased the rate of incorporation by 56%. Dibutyryl cyclic AMP plus theophylline stimulation was 63% of control in the absence of dexamethasone, and 154% of control in the presence of dexamethasone.
There was no effect of dexamethasone on the pantothenate content of the cells. In these experiments, the pantothenate content of incubations containing either glucagon or dibutyryl cyclic AMP plus theophylline was significantly elevated relative to controls (P < 0.01). However, the pantothenate content of the incubations containing only dexamethasone did not differ from controls. The presence of dexamethasone also had little effect on the pantothenate concentration of cells containing glucagon or dibutyryl cyclic AMP plus theophylline. The specific radioactivity of the intracellular pantothenate was approximately the same for all incubations (Table 3) , and the protein content of the cells did not differ significantly between various conditions (P > 0.05).
Although there was no effect of dexamethasone in the absence of glucagon or dibutyryl cyclic AMP plus theophylline, an effect of dexamethasone could (Fig. 4) . In the absence of dexamethasone, addition of 0.3 nM-glucagon had no effect, or resulted in a slight decrease in the rate of incorporation. In the presence of 0.5 pM-dexamethasone, 0.3 nM-glucagon stimulated the rate of incorporation by about 5096. At 3,uM-glucagon, which was well above the glucagon concentration required for saturating glucagon activation, the addition of dexamethasone caused a further 2-fold increase in the rate of incorporation. (Table 3 ). The enhancement of the glucagon effect by dexamethasone resembles, in part, the pattern of hormonal induction of the liver enzymes, tyrosine aminotransferase and phosphoenolpyruvate carboxykinase. Both glucagon and cyclic AMP are capable of inducing these two enzymes in vivo (Wicks et al., 1969 (Wicks et al., , 1972 . Furthermore, glucocorticoids are capable of inducing tyrosine aminotransferase in liver and additive inductive effects are observed in the presence of cyclic AMP or glucagon (Wicks et al., 1969) . The observed increase in activity of tyrosine aminotransferase by cyclic AMP and glucocorticoids are a result of enzyme synthesis de novo (Nickol et al., 1978; Ernst & Feigelson, 1978) . A relationship between cyclic AMP and glucocorticoid action was suggested by the fact that HTC hepatoma cells did not induce tyrosine aminotransferase upon exposure to cyclic AMP unless the cells were first exposed to dexamethasone (Granner et al., 1977) . In contrast, the Reuber H35 hepatoma cells were sensitive to the cyclic nucleotides in the absence of glucocorticoids (Barnett & Wicks, 1971) . In primary cultures of hepatocytes, phosphoenolpyruvate carboxykinase was induced with cyclic AMP (Savage & Bonney, 1978; Oliver et al., 1978) and tyrosine aminotransferase with either cyclic AMP (Bonney & Savage, 1979) or dexamethasone (Savage & Bonney, 1978) . Furthermore, the presence of both cyclic AMP and dexamethasone caused additive increases in tyrosine aminotransferase activity (Bonney & Savage, 1979) . In contrast with the above experiments with tyrosine aminotransferase and phosphoenolpyruvate carboxykinase, increases in the rate of panothenate conversion to CoA were not achieved by the addition of dexamethasone alone, and dexamethasone appeared to act synergistically with either glucagon or cyclic AMP. The difference between the dexamethasone effect on pantothenate incorporation and the induction of tyrosine aminotransferase could be in the mechanism of dexamethasone activation itself, or in the fact that our parameter for activation is flux through a multienzyme pathway. Any of the stimulatory agents might affect more than one locus of the biosynthetic and/or degradative pathway, so that there was no net effect on the incorporation of labelled precursor into final product.
Addition of glucagon or insulin to the hepatocytes in culture produced changes in the rates of pantothenate incorporation into CoA that were quantitatively consistent with changes in rates observed in vivo caused by starving and feeding rats (Smith, 1978) . In vivo, the rate of pantothenate conversion to CoA measured in the starved rat 2 h after intravenous injection of ['4C ]pantothenate was about 4.5 nmol/h per g wet wt. of liver and about 1.9 nmol/h per g wet wt. of liver in rats given glucose at the time of injection (Smith, 1978) . With the hepatocytes, rates varied from 14.0 nmol/h per g wet wt.
[assuming 20% protein for conversion (Diem & Letner, 1973) ] to 2.3 nmol/h per g wet wt. The rate increased from 2.3 nmol/h per g wet wt. to 5.3 when 1 m-i.u of insulin was replaced with 30nM-glucagon. The increase in total CoA during food deprivation overnight was 229 nmol of CoA/g wet wt. of liver in 20h, or an increase of at least 1 1.0nmol/h per g wet wt. .
Although addition of glucagon and dexamethasone produced changes in pantothenate incorporation into CoA in hepatocytes that were quantitatively similar to the changes observed during starvation and feeding in vivo, it is difficult to assess the contribution of changes in the circulating concentration of glucagon or glucocorticoid to the physiological alterations in total CoA concentrations in the liver. The concentration of dexamethasone required for the maximum response in the cultured hepatocytes was 50nM, which is comparable with the physiological glucocorticoid concentrations ranging from 10 to lOOnM (Wicks et al., 1974) . Although glucagon concentration required for half-maximal effect (approx. 3 nm) is considerably greater than the concentration of pancreatic glucagon thought to be in the circulation (Fisher et al.) , it is comparable with the concentrations used by Birnbaum & Fain (1977) for protein kinase-related activations in isolated liver cells. Sherwin & Felig (1974) have suggested that changes in circulating concentrations of pancreatic glucagon are too small to account for most physiological responses to food ingestion. However, in a situation such as this where the stimulatory effects of glucagon and dexamethasone are synergistic, small changes of one or the other are accentuated. In the physiological situation, an increase in glucagon and/or glucocorticoid might also be accompanied by regulatory effects from a decrease in insulin or a change in metabolite concentrations. An influx of fatty acids, for instance, could stimulate an increase in total CoA by decreasing the free CoASH concentration through acylation and relieving the feedback inhibition of pantothenate kinase (Abiko et al., 1972; Smith et al., 1978) 
